This provider averages 117 services per working day
Based on 291.4K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $6.2M in total Medicare payments ranks in the 97th percentile of Hematology-Oncology providers nationally.
Averaging 117 services per working day raises questions about billing patterns.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $247.66 | $80.30 | 3.08x | $167.36 | $772.6K | 27.4K | 6.2K |
| 2015 | $103.49 | $31.04 | 3.33x | $72.45 | $564.9K | 25.5K | 6.7K |
| 2016 | $102.27 | $30.36 | 3.37x | $71.91 | $736.9K | 34.8K | 9.5K |
| 2017 | $131.51 | $41.23 | 3.19x | $90.28 | $583.9K | 26.4K | 8.3K |
| 2018 | $118.92 | $40.23 | 2.96x | $78.69 | $713.6K | 29.0K | 10.2K |
| 2019 | $107.96 | $32.42 | 3.33x | $75.54 | $621.8K | 29.4K | 10.4K |
| 2020 | $105.61 | $31.24 | 3.38x | $74.37 | $596.5K | 31.4K | 10.0K |
| 2021 | $104.56 | $32.71 | 3.20x | $71.85 | $569.9K | 29.5K | 10.9K |
| 2022 | $89.00 | $33.74 | 2.64x | $55.26 | $532.5K | 27.8K | 10.1K |
| 2023 | $63.49 | $30.13 | 2.11x | $33.36 | $545.5K | 30.2K | 10.6K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 13.6K | $1.3M | $96.52 | 3.46x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 6.9K | $459.3K | $66.30 | 3.20x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 3.3K | $432.9K | $132.67 | 4.36x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 4.2K | $276.7K | $65.71 | 2.62x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 22.9K | $208.3K | $9.11 | 3.10x |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | 1.1K | $202.4K | $178.49 | 2.94x |
| 80053 | Blood test, comprehensive group of blood chemicals | 21.1K | $190.6K | $9.04 | 3.87x |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | 1.8K | $164.8K | $93.83 | 3.53x |
| 82728 | Ferritin (blood protein) level | 10.6K | $163.6K | $15.49 | 2.92x |
| 83735 | Magnesium level | 20.3K | $158.4K | $7.80 | 2.56x |
| J2505 | Injection, pegfilgrastim, 6 mg | 58 | $149.5K | $2.6K | 2.68x |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 1.8K | $126.8K | $72.08 | 3.27x |
| 82378 | Carcinoembryonic antigen (CEA) protein level | 5.4K | $114.6K | $21.37 | 2.92x |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 3.9K | $114.2K | $29.04 | 3.75x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 531 | $99.5K | $187.33 | 2.94x |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 5.7K | $98.4K | $17.26 | 4.05x |
| J9310 | Injection, rituximab, 100 mg | 157 | $95.6K | $609.14 | 2.56x |
| 82607 | Cyanocobalamin (vitamin B-12) level | 5.5K | $89.7K | $16.38 | 2.82x |
| 84443 | Blood test, thyroid stimulating hormone (TSH) | 4.8K | $88.9K | $18.34 | 2.63x |
| 84100 | Phosphate level | 20.4K | $87.7K | $4.31 | 4.48x |
This provider submits charges 3.32 times higher than what Medicare actually pays.
A markup ratio of 3.32x means for every $100 Medicare pays, this provider initially charges $332. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data